Analysts’ Weekly Ratings Updates for Clorox (CLX)

Several analysts have recently updated their ratings and price targets for Clorox (NYSE: CLX):

• 5/1/2024 – Clorox had its price target lowered by analysts at Evercore ISI from $145.00 to $142.00. They now have an “underperform” rating on the stock.
• 5/1/2024 – Clorox had its price target lowered by analysts at Citigroup Inc. from $155.00 to $150.00. They now have a “neutral” rating on the stock.
• 5/1/2024 – Clorox had its price target lowered by analysts at UBS Group AG from $164.00 to $159.00. They now have a “neutral” rating on the stock.
• 5/1/2024 – Clorox had its price target lowered by analysts at JPMorgan Chase & Co. from $159.00 to $158.00. They now have a “neutral” rating on the stock.
• 4/17/2024 – Clorox had its “neutral” rating reaffirmed by analysts at DA Davidson. They now have a $162.00 price target on the stock.
• 4/17/2024 – Clorox had its price target lowered by analysts at Deutsche Bank Aktiengesellschaft from $155.00 to $151.00. They now have a “hold” rating on the stock.
• 4/16/2024 – Clorox had its price target lowered by analysts at Citigroup Inc. from $165.00 to $155.00. They now have a “neutral” rating on the stock.
• 4/10/2024 – Clorox had its price target lowered by analysts at Barclays PLC from $148.00 to $136.00. They now have an “underweight” rating on the stock.
• 4/2/2024 – Clorox had its “neutral” rating reaffirmed by analysts at Citigroup Inc.. They now have a $165.00 price target on the stock, down previously from $170.00.
• 3/26/2024 – Clorox was upgraded by analysts at Jefferies Financial Group Inc. from an “underperform” rating to a “hold” rating. They now have a $145.00 price target on the stock.
• 3/26/2024 – Clorox had its “equal weight” rating reaffirmed by analysts at Morgan Stanley. They now have a $160.00 price target on the stock.

Clorox Stock Down 5.6 %

Shares of NYSE CLX opened at $139.64 on Thursday. The stock has a market cap of $17.33 billion, a PE ratio of 72.35, a price-to-earnings-growth ratio of 2.34 and a beta of 0.44. The Clorox Company has a 52-week low of $114.68 and a 52-week high of $178.21. The business has a 50-day moving average price of $149.00 and a 200 day moving average price of $143.10. The company has a quick ratio of 0.57, a current ratio of 0.89 and a debt-to-equity ratio of 11.37.

Clorox (NYSE:CLX) last released its quarterly earnings results on Tuesday, April 30th. The company reported $1.71 EPS for the quarter, beating the consensus estimate of $1.33 by $0.38. The firm had revenue of $1.81 billion during the quarter, compared to the consensus estimate of $1.87 billion. Clorox had a net margin of 3.33% and a return on equity of 305.36%. Clorox’s revenue for the quarter was down 5.3% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.51 EPS. Equities research analysts forecast that The Clorox Company will post 5.52 earnings per share for the current year.

Clorox Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 10th. Shareholders of record on Wednesday, April 24th will be given a dividend of $1.20 per share. The ex-dividend date of this dividend is Tuesday, April 23rd. This represents a $4.80 dividend on an annualized basis and a yield of 3.44%. Clorox’s payout ratio is currently 248.71%.

Institutional Investors Weigh In On Clorox

Institutional investors have recently added to or reduced their stakes in the business. abrdn plc boosted its position in shares of Clorox by 20.1% during the 4th quarter. abrdn plc now owns 198,250 shares of the company’s stock worth $28,268,000 after purchasing an additional 33,135 shares in the last quarter. International Assets Investment Management LLC lifted its position in shares of Clorox by 17,658.5% during the 4th quarter. International Assets Investment Management LLC now owns 484,453 shares of the company’s stock valued at $69,078,000 after acquiring an additional 481,725 shares during the period. Adage Capital Partners GP L.L.C. acquired a new stake in shares of Clorox during the 3rd quarter valued at approximately $6,605,000. Eagle Rock Investment Company LLC acquired a new stake in shares of Clorox in the 4th quarter worth approximately $2,940,000. Finally, Federated Hermes Inc. increased its stake in Clorox by 483.8% in the 4th quarter. Federated Hermes Inc. now owns 27,696 shares of the company’s stock valued at $3,949,000 after purchasing an additional 22,952 shares in the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.